Information VX-150 (EOS-62073), a NaV1.8 blocker, is currently in a phase II clinical trial for the treatment of patients with acute pain. VX-150 significantly alleviates postoperative pain.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
VX-150
CAS number:1793080-72-4 molecular formula:C21H17F4N2O7P
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | EOS-62073 | ||
| CAS number | 1793080-72-4 | molecular formula | C21H17F4N2O7P |
| molecular weight | 516.34 g/mol | Exact mass | 10mM in DMSO |
| PSA | 125.000 Ų | logp | 2.100 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





